These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1545128)

  • 1. Role of protein tyrosine phosphorylation in monokine induction by the staphylococcal superantigen toxic shock syndrome toxin-1.
    Scholl PR; Trede N; Chatila TA; Geha RS
    J Immunol; 1992 Apr; 148(7):2237-41. PubMed ID: 1545128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial superantigens induce NF-kappa B in the human monocytic cell line THP-1.
    Trede NS; Castigli E; Geha RS; Chatila T
    J Immunol; 1993 Jun; 150(12):5604-13. PubMed ID: 8515079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA class II molecule-mediated signal transduction mechanism responsible for the expression of interleukin-1 beta and tumor necrosis factor-alpha genes induced by a staphylococcal superantigen.
    Matsuyama S; Koide Y; Yoshida TO
    Eur J Immunol; 1993 Dec; 23(12):3194-202. PubMed ID: 8258334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional activation of IL-1 beta and tumor necrosis factor-alpha genes by MHC class II ligands.
    Trede NS; Geha RS; Chatila T
    J Immunol; 1991 Apr; 146(7):2310-5. PubMed ID: 2005400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activator protein-1 (AP-1) is stimulated by microbial superantigens in human monocytic cells.
    Trede NS; Chatila T; Geha RS
    Eur J Immunol; 1993 Sep; 23(9):2129-35. PubMed ID: 8370396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect between CD40 and class II signals overcome the requirement for class II dimerization in superantigen-induced cytokine gene expression.
    Mehindate K; al-Daccak R; Damdoumi F; Mourad W
    Eur J Immunol; 1996 Sep; 26(9):2075-80. PubMed ID: 8814249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early activation events induced by the staphylococcal superantigen toxic shock syndrome toxin-1 in human peripheral blood monocytes.
    Trede NS; Morio T; Scholl PR; Geha RS; Chatila T
    Clin Immunol Immunopathol; 1994 Feb; 70(2):137-44. PubMed ID: 8299229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining a novel domain of staphylococcal toxic shock syndrome toxin-1 critical for major histocompatibility complex class II binding, superantigenic activity, and lethality.
    Kum WW; Laupland KB; Chow AW
    Can J Microbiol; 2000 Feb; 46(2):171-9. PubMed ID: 10721486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional and translational control of TNF-alpha gene expression in human monocytes by major histocompatibility complex class II ligands.
    Espel E; Garcia-Sanz JA; Aubert V; Menoud V; Sperisen P; Fernández N; Spertini F
    Eur J Immunol; 1996 Oct; 26(10):2417-24. PubMed ID: 8898955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engagement of MHC class II molecules by staphylococcal superantigens activates src-type protein tyrosine kinases.
    Morio T; Geha RS; Chatila TA
    Eur J Immunol; 1994 Mar; 24(3):651-8. PubMed ID: 7510238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of binding domains on the superantigen, toxic shock syndrome-1, for class II MHC molecules.
    Soos JM; Russell JK; Jarpe MA; Pontzer CH; Johnson HM
    Biochem Biophys Res Commun; 1993 Mar; 191(3):1211-7. PubMed ID: 8466498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylococcus aureus-superantigen decreases FKBP51 mRNA expression and cell-response to suppressive efficacy of a glucocorticoid in human peripheral blood mononuclear cells: possible implication of mitogen-activated protein kinase pathways.
    Fukushima H; Hirano T; Oka K
    Eur J Pharmacol; 2007 Sep; 570(1-3):222-8. PubMed ID: 17610867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staphylococcal enterotoxin D is a promiscuous superantigen offering multiple modes of interactions with the MHC class II receptors.
    Al-Daccak R; Mehindate K; Damdoumi F; Etongué-Mayer P; Nilsson H; Antonsson P; Sundström M; Dohlsten M; Sékaly RP; Mourad W
    J Immunol; 1998 Jan; 160(1):225-32. PubMed ID: 9551975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification from a phage display library of peptides that bind to toxic shock syndrome toxin-1 and that inhibit its binding to major histocompatibility complex (MHC) class II molecules.
    Sato A; Ida N; Fukuyama M; Miwa K; Kazami J; Nakamura H
    Biochemistry; 1996 Aug; 35(32):10441-7. PubMed ID: 8756700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The alpha 1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1.
    Karp DR; Teletski CL; Scholl P; Geha R; Long EO
    Nature; 1990 Aug; 346(6283):474-6. PubMed ID: 2377209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissection of the function of HLA class II and costimulation in B cell-mediated and toxic shock syndrome toxin-1-induced T cell proliferation.
    Dennig D; O'Reilly RJ
    J Immunol; 1993 Jun; 150(12):5231-40. PubMed ID: 7685791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MHC class II molecules deliver costimulatory signals in human T cells through a functional linkage with IL-2-receptors.
    Odum N; Kanner SB; Ledbetter JA; Svejgaard A
    J Immunol; 1993 Jun; 150(12):5289-98. PubMed ID: 8515060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of T cell receptors engineered for high affinity against toxic shock syndrome toxin-1.
    Buonpane RA; Moza B; Sundberg EJ; Kranz DM
    J Mol Biol; 2005 Oct; 353(2):308-21. PubMed ID: 16171815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial superantigens induce down-modulation of CC chemokine responsiveness in human monocytes via an alternative chemokine ligand-independent mechanism.
    Rahimpour R; Mitchell G; Khandaker MH; Kong C; Singh B; Xu L; Ochi A; Feldman RD; Pickering JG; Gill BM; Kelvin DJ
    J Immunol; 1999 Feb; 162(4):2299-307. PubMed ID: 9973507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling of receptor mimics that inhibit superantigen pathogenesis.
    Möllhoff M; Zanden HB; Shiflett PR; Gupta G
    J Mol Recognit; 2005; 18(1):73-83. PubMed ID: 15459942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.